Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish

Parkinson’s disease is a common neurodegenerative disorder leading to severe disability. The clinical features reflect progressive neuronal loss, especially involving the dopaminergic system. The causes of Parkinson’s disease are slowly being uncovered and include both genetic and environmental insu...

Full description

Bibliographic Details
Main Authors:	Lisa M. Barnhill, Hiromi Murata, Jeff M. Bronstein
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Biomedicines
Subjects:	Parkinson’s disease zebrafish toxins dopaminergic neuron
Online Access:	https://www.mdpi.com/2227-9059/8/7/197

Similar Items

The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
by: Khairiah Razali, et al.
Published: (2021-04-01)

Effects of different concentrations of dimethylsulfoxide on development of zebrafish embryos and dopamine neurons
by: GAN Jinfan, et al.
Published: (2019-08-01)

Roles of stem cells in the treatment of Parkinson's disease
by: Yasaman Ebrahimikia, et al.
Published: (2018-10-01)

Excessive Daytime Sleepiness in Parkinson’s Disease
by: Liu H, et al.
Published: (2022-09-01)

Current status of stem cell-derived therapies for Parkinson’s disease : from cell assessment and imaging modalities to clinical trials
by: Jang, Se Eun, et al.
Published: (2021)

A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
by: Giselle Prunell, et al.
Published: (2022-11-01)

Parkinson’s disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010-11-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Chemical Genetics Screen Identifies Epigenetic Mechanisms Involved in Dopaminergic and Noradrenergic Neurogenesis in Zebrafish
by: Markus Westphal, et al.
Published: (2020-02-01)

Brain‐derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease
by: E Chang, et al.
Published: (2021-08-01)

Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
by: Longping Yao, et al.
Published: (2021-07-01)

Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
by: Xin He, et al.
Published: (2021-11-01)

Understanding miRNA Based Gene Regulation in Parkinson’s Disease: An in silico Approach
by: Surya Narayan Rath, et al.
Published: (2020-03-01)

A zebrafish model of manganism reveals reversible and treatable symptoms that are independent of neurotoxicity
by: Subha Bakthavatsalam, et al.
Published: (2014-11-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

Morpho-Anatomical Degeneration of Dopaminergic Neurons in Adult Zebrafish Brain after Exposure to Nickel
by: Pietro Cacialli, et al.
Published: (2024-08-01)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson’s disease.
by: Marta Raquel Carrola Esteves, et al.
Published: (2015-03-01)

Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy
by: Khalid M. Alharthy, et al.
Published: (2024-02-01)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
by: Noor Azzizah Omar, et al.
Published: (2023-08-01)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
by: Byounggook Cho, et al.
Published: (2024-11-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
by: Hanwen Zhang, et al.
Published: (2022-06-01)

ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease
by: Masaki Nakano, et al.
Published: (2017-08-01)

Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways
by: Jun Sung Park, et al.
Published: (2023-08-01)

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
by: Katrin Simmnacher, et al.
Published: (2020-01-01)

A novel curcumin oil solution can better alleviate the motor activity defects and neuropathological damage of a Parkinson’s disease mouse model
by: Xiwen Geng, et al.
Published: (2022-07-01)

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson’s Disease
by: Christelle Lasbleiz, et al.
Published: (2019-02-01)

Glial cells improve Parkinson’s disease by modulating neuronal function and regulating neuronal ferroptosis
by: Mengzhu Li, et al.
Published: (2025-01-01)

Rotenone Neurotoxicity Causes Dopamine Neuron Loss in Zebrafish
by: Simon Martel, et al.
Published: (2015-11-01)

Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson's disease
by: Majid Jadidi, et al.
Published: (2016-07-01)

CRISPR/Cas9-based QF2 knock-in at the tyrosine hydroxylase (th) locus reveals novel th-expressing neuron populations in the zebrafish mid- and hindbrain
by: Christian Altbürger, et al.
Published: (2023-08-01)

Targeting microglial NLRP3 in the SNc region as a promising disease‐modifying therapy for Parkinson's disease
by: Chen Qiao, et al.
Published: (2022-11-01)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
by: Jie Dong, et al.
Published: (2021-03-01)

Convolutional Neural Network-Based Parkinson Disease Classification Using SPECT Imaging Data
by: Jigna Hathaliya, et al.
Published: (2022-07-01)

Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson’s disease
by: Yong Hui Nies, et al.
Published: (2025-01-01)

The role of NURR1 in metabolic abnormalities of Parkinson’s disease
by: Murad Al-Nusaif, et al.
Published: (2022-06-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model
by: Noor Azzizah Omar, et al.
Published: (2023-11-01)